Biotech unicorn Moderna files for IPO of up to $500M
One of the biotech industry's largest unicorns, Cambridge-based Moderna Therapeutics, is planning to go public with an IPO of as much as $500 million, according to documents filed Friday. Moderna is developing messenger RNA molecules, including cancer vaccines, that executives estimates could impact dozens of diseases. The company currently has 10 drug products in clinical trials and another 11 drugs in preclinical development. The company filed documents with the SEC on Friday t o seek up to… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 9, 2018 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

Childhood Cancer Survivors Benefit From HPV Vaccine Childhood Cancer Survivors Benefit From HPV Vaccine
When healthcare providers recommend the HPV vaccine to survivors of childhood cancer, the patients take the advice to heart and are more likely to get vaccinated, according to new research.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2018 Category: Consumer Health News Tags: Pediatrics News Source Type: news

Health Tip: Understanding the HPV Vaccine
-- The HPV vaccine protects against human papillomavirus, which has been shown to cause cancer in males and females, the American Cancer Society says. More than 270 million doses have been administered since 2006, reports the society, saying studies... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 8, 2018 Category: General Medicine Source Type: news

HPV Vaccination Rates Continue to Lag in U.S.
Title: HPV Vaccination Rates Continue to Lag in U.S.Category: Health NewsCreated: 11/6/2018 12:00:00 AMLast Editorial Review: 11/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 7, 2018 Category: Cancer & Oncology Source Type: news

HPV Vaccination Rates Continue to Lag in U.S.
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - November 7, 2018 Category: Cancer & Oncology Source Type: news

Too Few Americans Get The HPV Vaccine
HPV (human papillomavirus) vaccination has increased in recent years, rates remain well below the government's 2020 goal of 80 percent of age-eligible adolescents, according to a recent report by the President’s Cancer Panel. (Source: WebMD Health)
Source: WebMD Health - November 6, 2018 Category: Consumer Health News Source Type: news

HPV Vaccination Rates Continue to Lag in U.S.
TUESDAY, Nov. 6, 2018 -- HPV vaccination rates are still too low to cut cervical cancer cases as much as is possible in the United States, a new report warns. While HPV (human papillomavirus) vaccination has increased in recent years, rates remain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 6, 2018 Category: General Medicine Source Type: news

HPV Vaccine Uptake Low Despite Prior Calls to Action HPV Vaccine Uptake Low Despite Prior Calls to Action
More action is needed to increase HPV vaccine uptake in the United States and elsewhere, according to the President's Cancer Report.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 5, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Public awareness of mouth cancer symptoms low, despite sharp rise in cases
Disease accounts for more than 8000 diagnoses and nearly 3000 deaths every year Related items fromOnMedica JCVI recommends universal HPV vaccination One or two doses of HPV jab may be enough Scotland launches its ‘Detect Cancer Early’ campaign Ditch habit for longer survival after head and neck cancer, smokers urged Obesity as cause of cancer set to overtake smoking (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 5, 2018 Category: UK Health Source Type: news

HPV Vaccination Uptake Increasing, but Still Too Low
FRIDAY, Nov. 2, 2018 -- Although progress has been made in increasing human papillomavirus (HPV) vaccination, coverage is still too low to achieve full cancer prevention potential, according to a report from the President's Cancer Panel published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 2, 2018 Category: Pharmaceuticals Source Type: news

A culturally tailored intervention increased HPV vaccination of Asian-American adolescents
(American Association for Cancer Research) A culturally tailored multilevel strategy designed to remove barriers to human papillomavirus (HPV) vaccination among low-income, mostly Chinese-American adolescent girls and boys significantly increased vaccine uptake. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2018 Category: Cancer & Oncology Source Type: news

New test could mean cervical cancer screening could stop sooner
Women with negative HPV DNA test may not need ongoing screening Related items fromOnMedica JCVI recommends universal HPV vaccination Experts call for wider HPV vaccination Some doctors misunderstand smear test says GP Vaccinating girls against HPV benefits men Parents unsure of HPV vaccine for daughters (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 2, 2018 Category: UK Health Source Type: news

Who Should Be Getting the HPV Vaccine Now? Who Should Be Getting the HPV Vaccine Now?
A recent expanded age indication gives PCPs another chance to prevent HPV-related cancer.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 30, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Combination immunotherapy with IL-2 surface-modified tumor cell vaccine and PD-1 blockade against renal cell carcinoma
Studies show that immunotherapy may be an effective way to prevent postoperative recurrence of renal cell carcinoma.10/29/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - October 29, 2018 Category: Urology & Nephrology Source Type: news

Oncologists demand more education on the use of biosimilars: ESMO takes action
(European Society for Medical Oncology) Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines -- but they are also expensive. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer
(City of Hope) Researchers from City of Hope have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer. Their novel two-step strategy eliminates STAT3 and toll-like receptor 9. The short DNA programmed by City of Hope researchers temporarily lifted the defense shield of tumors and awakened the immune system in human cell and mouse models to eradicate difficult-to-treat prostate cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 18, 2018 Category: Cancer & Oncology Source Type: news

Immune Design lays off workers and shifts course after halting lead cancer vaccine trial
The layoffs amount to about 20 percent of Immune Design's workforce in Seattle and San Francisco. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 16, 2018 Category: Biotechnology Authors: Casey Coombs Source Type: news

UCLA neurosurgeon named to National Academy of Medicine
Dr. Linda Liau, an internationally renowned neurosurgeon-scientist and chair of the neurosurgery department at theDavid Geffen School of Medicine at UCLA, has been elected by her peers to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.Membership honors people who have demonstrated outstanding professional achievements, commitment to service and contributions to the advancement of the medical sciences, health care and public health.A scientist in UCLA ’sJonsson Comprehensive Cancer Center, Liau has devoted the past 25 years to developing and refining treatment strategi...
Source: UCLA Newsroom: Health Sciences - October 15, 2018 Category: Universities & Medical Training Source Type: news

Cancer vaccine developer restructures after axing lead drug trial
Immune Design's stock price dropped more than 30 percent on the decision, which pushes the prospects of FDA approval several years into the future. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 12, 2018 Category: Pharmaceuticals Authors: Casey Coombs Source Type: news

Cancer vaccine developer restructures after axing lead drug trial
Immune Design's stock price dropped more than 30 percent on the decision, which pushes the prospects of FDA approval several years into the future. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 12, 2018 Category: Biotechnology Authors: Casey Coombs Source Type: news

Is the next big step in cancer therapy personalized vaccines?
(University of California - San Diego) Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 12, 2018 Category: Biology Source Type: news

Mayo Clinic researchers study immunity-boosting vaccine to target aggressive form of breast cancer
Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be to harness the full capabilities of the body?s immune system to do both jobs. On Mayo Clinic?s Florida campus, a team of researchers has a new anti-cancer vaccine in the [...] (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - October 10, 2018 Category: Hospital Management Source Type: news

HER2-Targeted Cancer Vaccine Shows Promise in Early Trial
A novel cancer vaccine targeting HER2-positive malignancies has progressed quickly from mouse trials into early-phase human trials, with promising results. (Source: CancerNetwork)
Source: CancerNetwork - October 9, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

HPV Vaccine Approved for People Through Age 45
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - October 9, 2018 Category: Cancer & Oncology Source Type: news

WATCH: HPV vaccine approved for men and women ages 27 to 45
Dr. Jennifer Ashton discusses what to know about the HPV vaccine now being approved for an older age group, and who should get the vaccine, which is meant to prevent cervical cancer. (Source: ABC News: Health)
Source: ABC News: Health - October 8, 2018 Category: Consumer Health News Tags: GMA Source Type: news

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
The U.S. Food and Drug Administration approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine. (Source: World Pharma News)
Source: World Pharma News - October 8, 2018 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

FDA expands use of HPV vaccine to adults 27 to 45
The FDA approved the HPV vaccine Gardasil 9 for use in adults ages 27 to 45 after studies showed it provided protection against genital warts and certain cancers. (Source: CNN.com - Health)
Source: CNN.com - Health - October 6, 2018 Category: Consumer Health News Source Type: news

HPV Vaccine Expanded for People Ages 27 to 45
The Food and Drug Administration has approved the use of Gardasil 9, a vaccine against nine strains of the human papillomavirus for older age groups. (Source: NYT Health)
Source: NYT Health - October 6, 2018 Category: Consumer Health News Authors: DENISE GRADY and JAN HOFFMAN Tags: Human Papillomavirus (HPV) Gardasil (Vaccine) Vaccination and Immunization Sexually Transmitted Diseases Food and Drug Administration Merck & Company Inc Cancer Source Type: news

Adults Up to Age 45 Can Now Get the HPV Vaccine
Adults up to age 45 can now be vaccinated against human papillomavirus (HPV), reducing their chances of getting cervical, oral and other cancers. The Food and Drug Administration (FDA) announced Friday that Gardasil 9, a vaccine that works against nine different types of HPV, is now approved for both men and women between the ages of 27 and 45. Previously, it was approved only for those between the ages of nine and 26, and recommended for all children at age 11 or 12. “Today’s approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range,” Dr. Peter M...
Source: TIME: Health - October 6, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

FDA approves HPV vaccine for people up to 45
Expanded vaccination age could boost efforts against HPV-caused cancers. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 5, 2018 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

FDA expands use of cervical cancer vaccine up to age 45
US regulators expand use of Merck's cervical cancer to women and men up to age 45 (Source: ABC News: Health)
Source: ABC News: Health - October 5, 2018 Category: Consumer Health News Tags: Health Source Type: news

More Than 14 Million Preteens Need to Receive HPV Vaccine
FRIDAY, Oct. 5, 2018 -- More than 14 million additional 11- to 12-year-olds need to be vaccinated to reach the American Cancer Society goal of 80 percent of adolescents being up to date (UTD) with the human papillomavirus vaccination (HPVV) by their... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 5, 2018 Category: Pharmaceuticals Source Type: news

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
(University of Helsinki) Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 5, 2018 Category: Cancer & Oncology Source Type: news

More Preteens Need HPV Shots to Meet Public Health Goal
THURSDAY, Oct. 4, 2018 -- Current rates of human papillomavirus (HPV) vaccination among preteens are too low to achieve goals set by the American Cancer Society, according to a new study. The cancer society wants an 80 percent vaccination rate... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 4, 2018 Category: General Medicine Source Type: news

How Scientists Are Treating Breast Cancer Using the Immune System
As a pharmacist, Kathy James considers herself well educated about the importance of getting regular cancer screenings. Even though the 55-year-old had no history of cancer in her family, she never skipped her regular mammograms, and she gave herself regular breast exams. So she was dumbfounded when, during one of those self-exams in May 2017, she felt a marble-size lump in her left breast. A visit to the doctor confirmed it. “The radiologist came in with his hands in his pockets and looked down and said, ‘It doesn’t look good,'” James says. After a biopsy, James and her husband learned she had meta...
Source: TIME: Health - October 4, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized breast cancer news Frontiers of Medicine Source Type: news

How Scientists Are Treating Breast Cancer Using the Immune System
As a pharmacist, Kathy James considers herself well educated about the importance of getting regular cancer screenings. Even though the 55-year-old had no history of cancer in her family, she never skipped her regular mammograms, and she gave herself regular breast exams. So she was dumbfounded when, during one of those self-exams in May 2017, she felt a marble-size lump in her left breast. A visit to the doctor confirmed it. “The radiologist came in with his hands in his pockets and looked down and said, ‘It doesn’t look good,'” James says. After a biopsy, James and her husband learned she had meta...
Source: TIME: Science - October 4, 2018 Category: Science Authors: Alice Park Tags: Uncategorized breast cancer news Frontiers of Medicine Source Type: news

HPV16 Vaccine Yields Added Benefit in Recurrent Throat Cancer
(MedPage Today) -- Response, survival double that of historical controls (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 3, 2018 Category: Hematology Source Type: news

Australia set to 'eliminate' cervical cancer by 2028
Australia is set to be the first country to eliminate cervical cancer, aided by its national vaccination and screening programs, says a new study, (Source: CNN.com - Health)
Source: CNN.com - Health - October 3, 2018 Category: Consumer Health News Source Type: news

Cervical cancer may be wiped out first in Australia
Researchers say the country is on track to eradicate the disease by 2035, if current vaccination and screening rates continue. Their prediction was made in The Lancet Public Health journal. (Source: the Mail online | Health)
Source: the Mail online | Health - October 3, 2018 Category: Consumer Health News Source Type: news

Vaccine Tx Shows Promise in HER2-Positive Cancers
(MedPage Today) -- Phase I data reveal activity in half of treated patients (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 2, 2018 Category: Hematology Source Type: news

Therapeutic Vaccine Shows Promise Against a Range of Cancers
Title: Therapeutic Vaccine Shows Promise Against a Range of CancersCategory: Health NewsCreated: 10/1/2018 12:00:00 AMLast Editorial Review: 10/2/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 2, 2018 Category: Cancer & Oncology Source Type: news

Nearly 14 million additional adolescents need HPV vaccination to reach public health goal
(American Cancer Society) Nearly 14 million additional adolescents will need to receive the human papillomavirus (HPV) vaccine to reach the American Cancer Society's goal of an 80 percent vaccination rate by that 2026. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 2, 2018 Category: Infectious Diseases Source Type: news

Vaccine Shows Promise Against a Range of Cancers
Using the patients' own blood cells, researchers at the U.S. National Cancer Institute modified immune cells and created personalized vaccines to target HER2-positive cancers throughout the bod (Source: WebMD Health)
Source: WebMD Health - October 1, 2018 Category: Consumer Health News Source Type: news

Therapeutic Vaccine Shows Promise Against a Range of Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 1, 2018 Category: Cancer & Oncology Tags: Infections, Oncology, Research, News, Source Type: news

New cancer vaccine shrunk 54% of tumors in NIH clinical trial
A new shot supercharges late-stage cancer patients' own immune systems to stop the growth of tumors that other treatments failed to slow, a new small National Institutes of Health trial revealed. (Source: the Mail online | Health)
Source: the Mail online | Health - October 1, 2018 Category: Consumer Health News Source Type: news

Medical News Today: New cancer vaccine may tackle HER2-positive tumors
A new cancer vaccine shows promise for treating a range of more aggressive HER2-positive cancers in an early, phase I clinical trial. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 1, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

New cancer vaccine can teach the immune system to 'see' rogue cells
One woman treated with the vaccine, which teaches the immune system to recognise rogue cells, saw her ovarian cancer disappear for more than 18 months. (Source: the Mail online | Health)
Source: the Mail online | Health - September 30, 2018 Category: Consumer Health News Source Type: news

Vaccine, drug combo promising against HPV-related cancers
Combining a tumor-specific vaccine with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to HPV in a trial. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 27, 2018 Category: Consumer Health News Source Type: news

Bill Gates Talks to TIME About a Coming ‘Third Wave’ of Development in Africa
There’s a very big difference between simple and easy—especially when it comes to global health. It’s simple to eradicate polio—just get all children are vaccinated. It’s simple to reduce nighttime malaria infections—make sure everyone in malaria-endemic areas sleeps under a bed net. But none of that is easy. The tension between simple and easy is at play when it comes to eradicating poverty in the developing world too, as the Bill & Melinda Gates Foundation makes clear in its second annual Goalkeepers Data Report. In a conversation with TIME, Bill Gates points to two recent waves of...
Source: TIME: Health - September 21, 2018 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized onetime public health Source Type: news

Medical News Today: Fighting brain cancer with the Zika virus
Scientists have found some surprising common ground between the Zika virus and brain cancer. They hope that a Zika vaccine may help combat glioblastoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 21, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news